scholarly article | Q13442814 |
P50 | author | Jena A Shaw | Q58056712 |
P2093 | author name string | Robert I Berkowitz | |
Thomas A Wadden | |||
Ariana M Chao | |||
Naji Alamuddin | |||
Zayna M Bakizada | |||
Olivia Walsh | |||
Sharon Leonard | |||
Kathryn Gruber | |||
P2860 | cites work | Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin | Q22250892 |
Benefits of lifestyle modification in the pharmacologic treatment of obesity: a randomized trial | Q31931766 | ||
Multilevel modeling of longitudinal data for psychotherapy researchers: II. The complexities | Q33534283 | ||
Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults | Q33737073 | ||
Multicenter, placebo-controlled trial of lorcaserin for weight management | Q34660152 | ||
Combining behavioral and pharmacological treatments for obesity | Q34675924 | ||
Biology's response to dieting: the impetus for weight regain | Q35217475 | ||
A two-year randomized trial of obesity treatment in primary care practice | Q35766121 | ||
Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide | Q36028436 | ||
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes | Q36050559 | ||
Association of Pharmacological Treatments for Obesity With Weight Loss and Adverse Events: A Systematic Review and Meta-analysis | Q36051581 | ||
Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans | Q37377728 | ||
Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE Maintenance randomized study | Q38449189 | ||
Effects of once-weekly semaglutide on appetite, energy intake, control of eating, food preference and body weight in subjects with obesity | Q41539948 | ||
Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans | Q42612217 | ||
How Strongly Does Appetite Counter Weight Loss? Quantification of the Feedback Control of Human Energy Intake | Q42696416 | ||
Agreement between weekly vs. daily assessment of appetite | Q44461762 | ||
Randomized trial of lifestyle modification and pharmacotherapy for obesity | Q46807914 | ||
Effects of liraglutide on weight, satiation, and gastric functions in obesity: a randomised, placebo-controlled pilot trial | Q47185132 | ||
Appetite sensations and satiety quotient: predictors of energy intake and weight loss | Q47317247 | ||
Liraglutide: short-lived effect on gastric emptying -- long lasting effects on body weight | Q47333623 | ||
Long-term persistence of hormonal adaptations to weight loss | Q47347342 | ||
A controlled comparison of three very-low-calorie diets: effects on weight, body composition, and symptoms | Q47414445 | ||
Glucagon-like peptide-1 promotes satiety and reduces food intake in patients with diabetes mellitus type 2. | Q48218648 | ||
Effect of Oxyntomodulin, Glucagon, GLP-1, and Combined Glucagon +GLP-1 Infusion on Food Intake, Appetite, and Resting Energy Expenditure. | Q51295926 | ||
Effect of the once-daily human GLP-1 analogue liraglutide on appetite, energy intake, energy expenditure and gastric emptying in type 2 diabetes. | Q51359175 | ||
Less food, less hunger: reports of appetite and symptoms in a controlled study of a protein-sparing modified fast | Q69423784 | ||
Behavior therapy and pharmacotherapy for obesity | Q70818490 | ||
Intensive Behavioral Therapy for Obesity Combined with Liraglutide 3.0 mg: A Randomized Controlled Trial | Q93027238 | ||
P433 | issue | 2 | |
P304 | page(s) | 353-361 | |
P577 | publication date | 2019-03-29 | |
P1433 | published in | International Journal of Obesity | Q6051519 |
P1476 | title | Effects of liraglutide on appetite, food preoccupation, and food liking: results of a randomized controlled trial | |
P478 | volume | 44 |
Q98894266 | Examination of a partial dietary self-monitoring approach for behavioral weight management | cites work | P2860 |
Search more.